Search research articles
Contact Us
Filters
Showing results (61-70 of 190) with videos related to
Page
of 19
Sort By:
Journal of Pain & Palliative Care Pharmacotherapy
|
December 21, 2017
Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US
Souvik Banerjee, Carl L Roland, Richard Willke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]
Louis P Garrison, Mark V Pauly, Richard J Willke, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and access
Louis P Garrison, Andrew W Lo, Richard S Finkel, et al.
BMC Medicine
|
January 29, 2024
Is the price right? Paying for value today to get more value tomorrow
Sreeram V Ramagopalan, Jose Diaz, Grace Mitchell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer
Josh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]
Richard J Willke, Peter J Neumann, Louis P Garrison, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 31, 2020
Development of a Sleep Apnea-Specific Health State Utility Algorithm
Jonathan R Skirko, Kathryn T James, Louis P Garrison, et al.
Journal of Cancer Research and Clinical Oncology
|
May 12, 2009
Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis
Josh John Carlson, Louis P Garrison, Scott D Ramsey, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 14, 2022
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer
Boshen Jiao, Yaw A Nyame, Josh J Carlson, et al.
Applied Health Economics and Health Policy
|
August 16, 2014
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"
Josh J Carlson, Katie Gries, Kai Yeung, et al.
Page
of 19
Search research articles
Search
Showing results (61-70 of 190) with videos related to
Sort By:
Page
of 19
Journal of Pain & Palliative Care Pharmacotherapy
|
December 21, 2017
Prevalence of and Comorbid Health Conditions Associated With Pediatric Prescription Opioid Use in the US
Souvik Banerjee, Carl L Roland, Richard Willke, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
An Overview of Value, Perspective, and Decision Context-A Health Economics Approach: An ISPOR Special Task Force Report [2]
Louis P Garrison, Mark V Pauly, Richard J Willke, et al.
American Journal of Medical Genetics. Part C, Seminars in Medical Genetics
|
March 1, 2023
A review of economic issues for gene-targeted therapies: Value, affordability, and access
Louis P Garrison, Andrew W Lo, Richard S Finkel, et al.
BMC Medicine
|
January 29, 2024
Is the price right? Paying for value today to get more value tomorrow
Sreeram V Ramagopalan, Jose Diaz, Grace Mitchell, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
July 24, 2008
The potential clinical and economic outcomes of pharmacogenomic approaches to EGFR-tyrosine kinase inhibitor therapy in non-small-cell lung cancer
Josh J Carlson, Louis P Garrison, Scott D Ramsey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research
|
February 26, 2018
Review of Recent US Value Frameworks-A Health Economics Approach: An ISPOR Special Task Force Report [6]
Richard J Willke, Peter J Neumann, Louis P Garrison, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
January 31, 2020
Development of a Sleep Apnea-Specific Health State Utility Algorithm
Jonathan R Skirko, Kathryn T James, Louis P Garrison, et al.
Journal of Cancer Research and Clinical Oncology
|
May 12, 2009
Epidermal growth factor receptor genomic variation in NSCLC patients receiving tyrosine kinase inhibitor therapy: a systematic review and meta-analysis
Josh John Carlson, Louis P Garrison, Scott D Ramsey, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 14, 2022
Does Clinical Evidence of Heterogeneity Impact Treatment Selection? A Case Study of Abiraterone for Metastatic Prostate Cancer
Boshen Jiao, Yaw A Nyame, Josh J Carlson, et al.
Applied Health Economics and Health Policy
|
August 16, 2014
Authors' reply to Curto and Garattini: "Current status and trends in performance-based risk-sharing arrangements between healthcare payers and medical product manufacturers"
Josh J Carlson, Katie Gries, Kai Yeung, et al.
Page
of 19